SCHEMBL11265712

SCHEMBL11265712

CC(CNCc1ccccc1)Oc1ccccc1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MTNR1A P48039 1/20 0.54
MTNR1B P49286 1/20 0.54
MCHR1 Q99705 2/20 0.52
BCHE P06276 4/20 0.50
DRD4 P21917 1/20 0.47
ALDH1A1 P00352 2/20 0.46
CYP1A2 P05177 1/20 0.46
CYP2D6 P10635 1/20 0.46
MEN1 O00255 3/20 0.45
KMT2A Q03164 3/20 0.45
TDP1 Q9NUW8 1/20 0.45
NPC1 O15118 1/20 0.43
RAB9A P51151 1/20 0.43
ANPEP P15144 1/20 0.42
KDM4E B2RXH2 1/20 0.42
HTT P42858 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
CASR P41180 1/20 0.42
SIGMAR1 Q99720 1/20 0.42
MITF O75030 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL749839 0.81 BCHE (0.49) MCHR1BCHEALDH1A1CYP1A2CYP2D6
SCHEMBL11148402 0.80 MCHR1 (0.57) MTNR1AMTNR1BMCHR1BCHECYP1A2
SCHEMBL15150547 0.80 MOGAT2 (0.49) MTNR1AMTNR1BBCHEMEN1KMT2A
SCHEMBL11155360 0.79 MCHR1 (0.56) MTNR1AMTNR1BMCHR1BCHEDRD4
Hydrochloric Acid SCHEMBL15140753 0.79 MOGAT2 (0.51) MTNR1AMTNR1BBCHEALDH1A1CYP1A2
SCHEMBL26871641 0.79 SMN1; SMN2 (0.47) MCHR1BCHEALDH1A1CYP1A2CYP2D6
SCHEMBL27686874 0.77 BCHE (0.46) MCHR1BCHEALDH1A1CYP1A2CYP2D6
SCHEMBL13452617 0.77 MTNR1A (0.61) MTNR1AMTNR1BALDH1A1KDM4ESMN1; SMN2
SCHEMBL28735087 0.77 SIGMAR1 (0.52) MTNR1AMTNR1BCYP2D6SIGMAR1
SCHEMBL2018449 0.77 MEN1 (0.56) BCHEALDH1A1CYP1A2CYP2D6MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4346093-A CARDIOVASCULAR DISORDERS BOEHRINGER MANNHEIM GMBH (DE) 1982-08-24 US disclosed
EP-0014951-A2 Heterocyclic oxypropanolamine derivatives, process for their preparation and medicines containing these compounds Roche Diagnostics GmbH (DE) 1980-09-03 EP disclosed